跳至主要内容
临床试验/CTRI/2021/05/033713
CTRI/2021/05/033713已完成2 期

Clinical Evaluation of Immunomodulatory Effect of Swarnaprashan in Children: A Prospective Open Label Study

ational Institute of Ayurveda Jaipur Rajasthan0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Children aged from 2-5 years of either sex
  • 2. Childern with recurrent respiratory infections
  • 3. Childern with recurrent G.I.T. diseases
  • 4. Children with recurrent fever
  • 5. Children with recuurent episodes of diarrhea
  • 6. Children with other recurrent diseases

排除标准

  • 1. Subjects suffering from major systemic illness necessitating long term treatment
  • 2. Subjects with evidence of malignancy
  • 3. Subject with aspartate amino transferase(AST) and or alanine amino transferase ALT >3 Times of the upper normal limit and renal dysfunction (Sr. creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction( asthmatic and COPD patients) .
  • 4. Co-morbidity like TB, UTI and bleeding disorders etc
  • 5. Congenital anomalies and hereditary disease.
  • 6. Pulmonary or abdominal tuberculosis.
  • 7. H/O hypersensitivity to any of the trial drug or any of its ingredients.
  • 8. Subjects who have completed participation in any other clinical trial during the past six months.
  • 9. Any contraindications mentioned for Lehan karma in Kashyap Samhita.

研究者

发起方
ational Institute of Ayurveda Jaipur Rajasthan

相似试验